bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas
1996

Expression of bcl-2, p53, and PCNA in Thyroid Carcinomas

Sample size: 134 publication Evidence: moderate

Author Information

Author(s): L Pollina, F Pacini, G Fontanini, S Vignati, G Bevilacqua, F Basolo

Primary Institution: Institute of Pathology, University of Pisa

Hypothesis

The expression of bcl-2 and p53 gene alterations is related to the degree of differentiation in thyroid carcinomas.

Conclusion

The study suggests that p53 and bcl-2 protein abnormalities are associated with more advanced thyroid carcinomas, particularly undifferentiated types.

Supporting Evidence

  • bcl-2 was expressed in 90% of adenomas and 100% of medullary carcinomas.
  • 62.5% of undifferentiated carcinomas showed p53 expression.
  • PCNA expression was significantly higher in undifferentiated carcinomas compared to other types.

Takeaway

This study looked at how certain proteins behave in thyroid cancer cells, finding that some proteins are linked to more aggressive forms of cancer.

Methodology

The study analyzed the expression of bcl-2, p53, and PCNA in thyroid tissues using immunocytochemistry on samples from 134 patients.

Limitations

The series is somewhat selected and may not reflect the biological history of thyroid carcinomas.

Participant Demographics

The study included 134 patients with primary malignant thyroid tumors, with a mean age of 49.2 years for well-differentiated carcinomas.

Statistical Information

P-Value

P = 0.035

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication